Pandemic onset stalled reduction of benzodiazepine use among older Americans, says study

Pandemic onset stalled reduction of benzodiazepine use among older Americans, says study. Years of progress in reducing benzodiazepine prescribing among older Americans stalled after the onset of the COVID-19 pandemic, according to a decade-long national study from Columbia University Mailman School of Public Health and Columbia University Irving Medical Center.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Years of progress in reducing benzodiazepine prescribing among older Americans stalled after the onset of the COVID-19 pandemic, according to a decade-long national study from Columbia University Mailman School of Public Health and Columbia University Irving Medical Center. Although benzodiazepine prescribing declined steadily before 2020 and remained below 2015 levels, those reductions leveled off after the pandemic began.

• Ponto de atenção: pandemic.
• Ponto de atenção: onset.
• Ponto de atenção: stalled.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.